Combined vitreoretinal-cataract system (VCS) is cleared for use in Canada New, proprietary technology is designed to deliver significant surgical and workflow efficiencies First innovation to be ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY ® Vitreoretinal Cataract System (VCS) and UNITY ® ...

“Alcon has a long legacy of advancing phaco and vitreoretinal technology for surgical ophthalmology. With UNITY VCS/CS, we are introducing more than a dozen innovations designed to transform surgical ...

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives.

Alcon (ALC) declined more than 10% on Wednesday after posting a mixed first-quarter print where revenue missed analysts’ consensus by $10M. The stock was trading 10.58% lower at $66.25 during midday ...

Vision Care delivered Q4 sales of $1.2 billion, up 7% year on year, as the segment benefited from innovation and pricing actions. Contact Lens revenue increased 4% to $683 million despite tough ...

On February 24, 2026, Alcon filed a Form 6-K with the U.S. SEC, attaching glossy pages of its 2025 Annual Report, which detail a year the company describes as transformative despite tariff pressures ...

“Today marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment solutions in cataract and vitreoretinal surgery, and we are grateful to those who helped us ...